News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zilver® PTX® Drug-Eluting Peripheral Stent From Cook Medical Qualifies for Additional Medicare Reimbursement


8/27/2013 9:21:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Effective October 1, Cook Medical’s Zilver® PTX® Drug-Eluting Peripheral Stent qualifies for new-technology add-on payments under Medicare’s hospital inpatient prospective payment system.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES